These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32446382)

  • 1. Kuanoniamine C stimulates bortezomib-induced cell death via suppression of glucose-regulated protein 78 in osteosarcoma.
    Machihara K; Namba T
    Biochem Biophys Res Commun; 2020 Jun; 527(1):289-296. PubMed ID: 32446382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRP78 inhibition enhances ATF4-induced cell death by the deubiquitination and stabilization of CHOP in human osteosarcoma.
    Luo J; Xia Y; Luo J; Li J; Zhang C; Zhang H; Ma T; Yang L; Kong L
    Cancer Lett; 2017 Dec; 410():112-123. PubMed ID: 28947141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Questiomycin A stimulates sorafenib-induced cell death via suppression of glucose-regulated protein 78.
    Machihara K; Tanaka H; Hayashi Y; Murakami I; Namba T
    Biochem Biophys Res Commun; 2017 Oct; 492(1):33-40. PubMed ID: 28811106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATF4 destabilizes RET through nonclassical GRP78 inhibition to enhance chemosensitivity to bortezomib in human osteosarcoma.
    Luo J; Xia Y; Yin Y; Luo J; Liu M; Zhang H; Zhang C; Zhao Y; Yang L; Kong L
    Theranostics; 2019; 9(21):6334-6353. PubMed ID: 31534554
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma.
    Abdel Malek MA; Jagannathan S; Malek E; Sayed DM; Elgammal SA; Abd El-Azeem HG; Thabet NM; Driscoll JJ
    Oncotarget; 2015 Feb; 6(5):3098-110. PubMed ID: 25605012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting HSP70 and GRP78 in canine osteosarcoma cells in combination with doxorubicin chemotherapy.
    Asling J; Morrison J; Mutsaers AJ
    Cell Stress Chaperones; 2016 Nov; 21(6):1065-1076. PubMed ID: 27631331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma.
    Xia YZ; Yang L; Xue GM; Zhang C; Guo C; Yang YW; Li SS; Zhang LY; Guo QL; Kong LY
    Oncotarget; 2016 Aug; 7(35):56371-56382. PubMed ID: 27486760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium chloride elicits apoptosis in human osteosarcoma U-2 OS cells through extrinsic signaling, intrinsic pathway and endoplasmic reticulum stress.
    Tsai YF; Huang CW; Chiang JH; Tsai FJ; Hsu YM; Lu CC; Hsiao CY; Yang JS
    Oncol Rep; 2016 Dec; 36(6):3421-3426. PubMed ID: 27748868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.
    Buontempo F; Orsini E; Lonetti A; Cappellini A; Chiarini F; Evangelisti C; Evangelisti C; Melchionda F; Pession A; Bertaina A; Locatelli F; Bertacchini J; Neri LM; McCubrey JA; Martelli AM
    Oncotarget; 2016 Jan; 7(2):1323-40. PubMed ID: 26593250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting GRP78 to enhance melanoma cell death.
    Martin S; Hill DS; Paton JC; Paton AW; Birch-Machin MA; Lovat PE; Redfern CP
    Pigment Cell Melanoma Res; 2010 Oct; 23(5):675-82. PubMed ID: 20546536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib and endocannabinoid/endovanilloid system: a synergism in osteosarcoma.
    Punzo F; Tortora C; Di Pinto D; Pota E; Argenziano M; Di Paola A; Casale F; Rossi F
    Pharmacol Res; 2018 Nov; 137():25-33. PubMed ID: 30267762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.
    Zhao A; Zhang Z; Zhou Y; Li X; Li X; Ma B; Zhang Q
    Phytomedicine; 2020 Apr; 69():153183. PubMed ID: 32113150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of small molecules targeting GRP78 for antiangiogenic and anticancer therapy.
    Qiao Y; Dsouza C; Matthews AA; Jin Y; He W; Bao J; Jiang F; Chandna R; Ge R; Fu L
    Eur J Med Chem; 2020 May; 193():112228. PubMed ID: 32199134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib.
    Jagannathan S; Abdel-Malek MA; Malek E; Vad N; Latif T; Anderson KC; Driscoll JJ
    Leukemia; 2015 Nov; 29(11):2184-91. PubMed ID: 26108695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nudol, a phenanthrene derivative from
    Zhang Y; Zhang Q; Xin W; Liu N; Zhang H
    Drug Des Devel Ther; 2019; 13():2591-2601. PubMed ID: 31551653
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel N-substituted benzamides as anti-migration agents for treatment of osteosarcoma.
    Chen X; Wang G; Mohammed Alsayed AM; Du Z; Lu Liu ; Ma Y; Liu P; Zhang Q; Chen X; Chen W; Ye F; Zheng X; Liu Z
    Eur J Med Chem; 2021 Mar; 214():113203. PubMed ID: 33530028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib sensitizes human osteosarcoma cells to adriamycin-induced apoptosis through ROS-dependent activation of p-eIF2α/ATF4/CHOP axis.
    Xian M; Cao H; Cao J; Shao X; Zhu D; Zhang N; Huang P; Li W; Yang B; Ying M; He Q
    Int J Cancer; 2017 Sep; 141(5):1029-1041. PubMed ID: 28524233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitriol exerts an anti-tumor effect in osteosarcoma by inducing the endoplasmic reticulum stress response.
    Shimizu T; Kamel WA; Yamaguchi-Iwai S; Fukuchi Y; Muto A; Saya H
    Cancer Sci; 2017 Sep; 108(9):1793-1802. PubMed ID: 28643892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAP1 role in endoplasmic reticulum stress protection favors resistance to anthracyclins in breast carcinoma cells.
    Sisinni L; Maddalena F; Lettini G; Condelli V; Matassa DS; Esposito F; Landriscina M
    Int J Oncol; 2014 Feb; 44(2):573-82. PubMed ID: 24297638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HHQ-4, a quinoline derivate, preferentially inhibits proliferation of glucose-deprived breast cancer cells as a GRP78 down-regulator.
    Xiao X; Li S; Zhang X; Lu J; Wang W; Zhou S; Zhang J; Wang R; Li A
    Toxicol Appl Pharmacol; 2019 Jun; 373():10-25. PubMed ID: 31022492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.